论文部分内容阅读
1950年1月至1977年8月应用阿扦品针剂,作为止血剂治疗肺结核咯血977例,现将其临床疗效分析报导如下。一般资料977例中,男性800例,女性177例。年龄最大68岁,最小19岁．肺结核病程最长18年,最短一月余。治疗方法硫酸阿托品1毫克至2毫克,皮下注射。疗效标准一,显效:注射一次即血止,24小时内不再咯血。二、好转:一次注射,暂时止血后,又继续咯血或咯血量减少者。
January 1950 to August 1977 application of Akebia needle injection, as a hemostatic agent for the treatment of 977 cases of pulmonary tuberculosis hemoptysis, now its clinical efficacy analysis reported as follows. General information 977 cases, 800 males and 177 females. The oldest is 68 years old and the youngest is 19 years old. Pulmonary tuberculosis course of up to 18 years, the shortest more than a month. Treatment atropine sulfate 1 mg to 2 mg, subcutaneous injection. Efficacy standards First, markedly effective: the injection of blood only once, no more hemoptysis within 24 hours. Second, improvement: an injection, temporary hemostasis, but also continue to reduce the amount of hemoptysis or hemoptysis.